Most often, Johnson & Johnson opens life science earnings season and shares the limelight with other companies reporting in that first week. For fourth-quarter and full-year 2023, J&J had the stage to itself.
Just after Johnson & Johnson’s (J&J’s) fourth-quarter earnings announcement its shares dipped modestly into negative territory in premarket trading. Glancing...